Pathology & Molecular Evidence
Convert reports into structured, traceable pathology and biomarker records.
One structured case record, checked by a clinician
Explore workflow
Live with 2 care organizations across Nigeria
Ireti
Precision oncology, connected.
Turn scattered pathology and molecular reports into one organized case for your cancer care team to review.
AI prepares. Your clinicians approve.
Built on AWS & Azure StacksGPU-accelerated AIClinician-reviewed by designDesigned for NDPA / NDPR alignment
The use case, in plain language
One case. Three connected jobs.
Prepare the evidence, bring specialists together, and keep the next step visible. Here is where Ireti fits into your team's working day.
For pathologists and laboratory teams
Turn separate reports into one review-ready case.
A pathology report arrives as a scan. The molecular results arrive in a separate PDF. The oncology team needs both before the next review.
- What comes in
- Scanned pathology reports and molecular test PDFs
- What Ireti does
- Ireti extracts findings, links each field to its source, and flags missing information for review.
- What comes out
- One structured case record, checked by a clinician
Pathology & molecular evidenceSynthetic data - illustration only
Case IR-2048
Breast oncology review
Original report / page 2
Pathology report
Specimen: breast tissue
Finding: invasive carcinoma
Collection date: not recorded
Extracted findings
- Specimen
- Breast tissue
- Finding
- Invasive carcinoma
- Source
- Pathology report, p. 2
Missing collection date
Clinicians review and approve every output before use.
From documents to discussion
The AI prepares. Your clinicians approve.
The result is a case summary with traceable sources, ready for specialist review.
- 01
Read
Ireti extracts key findings from scanned pathology reports, PDF lab results, and digital molecular test outputs.
- 02
Structure
The findings become one organized case record with traceable sources, missing fields, and inconsistencies clearly flagged.
- 03
Match evidence
The case is linked to relevant published guidelines and clinician-led trial navigation without replacing specialist judgment.
- 04
Prepare review
A tumor board summary is generated for specialists to review, edit, approve, and sign off.
Every output is reviewed, edited, and approved by a clinician before use.
Built around your team
Choose the workflow your team needs.
Each module handles a specific part of the case, while keeping the evidence and the handoff connected.
Tumor Board
Prepare multidisciplinary reviews with agendas, notes, decision logs, and follow-up actions.
A signed-off review summary with named follow-up actions
Explore workflow
Care Coordination
Give teams visibility into referral status, tasks, and follow-up scheduling.
A visible action list with an owner and status for each task
Explore workflowLess time chasing files
Keep the case moving between teams.
Shared records and visible follow-up actions help your team prepare for review and coordinate what happens next.
Faster case preparation
Traceable molecular evidence
Tumor board ready summaries
Referral and follow-up visibility
Specialist time relief
Flexible integration
Why the preparation matters
Cancer cases arrive as scattered reports.
Scanned pathology reports, PDF results, messages, and paper notes need to become a complete case before a specialist meeting can begin.
new cancer cases estimated across Africa in 2022
IARC Global Cancer Observatory, 2022cancer deaths estimated across Africa in 2022
IARC Global Cancer Observatory, 2022of cancer cases in Nigeria diagnosed at advanced stages (III & IV)
Nigeria National Cancer Control Plan (Federal Ministry of Health)Health organizations using the tech
Two healthcare partners live on Ireti.
Explore how leading tertiary hospitals and molecular reference laboratories deploy Ireti to structure oncology evidence and power clinician decision-making.
Tertiary Hospital & Cancer Center
Greencare Hospital
Lagos, NigeriaTertiary specialist hospital & multidisciplinary cancer care department
How they use the tech
Ingests scanned histopathology reports, IHC biomarker panels, and radiology findings across surgical, medical, and radiation oncology teams to assemble unified digital dossiers prior to weekly tumor board reviews.
Their clinical output
Case preparation time cut from 4.5 hours to 45 minutes (-80%); 100% source-traceable clinical summaries and signed-off treatment plans across 220+ patient reviews.
Molecular Pathology Reference Lab
Domlan Diagnostics
Lagos & Abuja, NigeriaSpecialist reference laboratory providing molecular oncology and cancer biomarker diagnostics
How they use the tech
Processes raw molecular assay outputs and genomic mutation panels (EGFR, KRAS, BRAF, HER2), structuring variant data into traceable clinical summaries directly accessible to referring oncology networks.
Their clinical output
Zero transcription errors in molecular biomarker handoffs, instant automated matching against NCCN/ESMO evidence guidelines, and direct digital reporting to 120+ referring cancer specialists.
Ireti by the numbers
A view of our work so far.
care organizations live
Pilot clinical deployments . Active clinical partner sitescases structured
Across partner sites . Internal case logsclinicians using Ireti
Active users . Internal user recordstumor board reviews prepared
Multidisciplinary reviews . Internal workflow logsSupporting the organizations behind cancer care
Hospitals
Pathology labs
Molecular diagnostics
Cancer networks
Research teams
Specialist clinics
Built for institutional care
Clear oversight at every step.
Source references, controlled access, and review history keep evidence preparation accountable to your clinical team.
Clinician oversight
Your specialists review and sign off before an output is used.
Cloud on AWS & Azure Stacks
Multi-cloud infrastructure supporting document processing, enterprise Microsoft Azure Stacks (Azure Health Data Services & hospital VPCs), and localized data residency.
AI acceleration with NVIDIA GPUs
GPU acceleration supports report extraction and evidence preparation.
Leadership
Built with clinical and operational experience.
Our leadership brings technology, partnerships, and clinical review into the same conversation.
Adeola Akinwale
Chief Executive Officer
Leads Ireti's institutional partnerships, product direction, and Nigeria-first growth strategy.
Tomiwa Bello
Chief Technology Officer
Oversees secure product engineering, report extraction workflows, and cloud deployment.
Research & insights
Thinking behind connected oncology care.
Operations insight
Why structured oncology evidence matters before the meeting starts
Read insightGovernance
Human oversight in AI-supported cancer care workflows
Read insightInfrastructure
Designing oncology data systems for African care networks
Read insightBetter-prepared cases.
Better-informed decisions.
Let's talk about the workflow your team needs.